Skip to main content
. 2020 Sep 3;44(5):2143–2151. doi: 10.3892/or.2020.7749

Figure 2.

Figure 2.

Association of FBLN5 expression with clinical information in patients with HGSOC. (A) Representative immunohistochemical staining of FBLN5 in HGSOC. (B) The high and low expression level of FBLN5 in 57 FT and 159 HGSOC tissues. (C) Overall survival rates in patients with HGSOC, with either high or low expression levels of FBLN5. (D) The multivariate analysis for OS. *P<0.05, **P<0.01. FBLN5, fibulin-5; HGSOC, high-grade serous ovarian cancer; FT, fallopian tube.